Clinical Trial Update: HYDROxychloroquine in Syndrome Primary AntiPhospholipid [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of hydroxychloroquine for antiphospholipid syndrome (including pregnancy) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Antiphospholipid Syndrome in Pregnancy, Anticoagulants | Phase 2 | Status: WITHDRAWN